Machine learning, pharmacogenomics, and clinical psychiatry: Predicting antidepressant response in patients with major depressive disorder

WV Bobo, B Van Ommeren… - Expert review of clinical …, 2022 - Taylor & Francis
Introduction The efficacy of antidepressants for patients with major depressive disorder
(MDD) varies from individual to individual, making the prediction of therapeutic outcomes …
被引用次数：7 相关文章

Machine learning, pharmacogenomics, and clinical psychiatry: predicting antidepressant response in patients with major depressive disorder

WV Bobo, B Van Ommeren… - Expert review of …, 2022 - mayoclinic.elsevierpure.com
Introduction: The efficacy of antidepressants for patients with major depressive disorder
(MDD) varies from individual to individual, making the prediction of therapeutic outcomes …

Machine learning, pharmacogenomics, and clinical psychiatry: predicting antidepressant response in patients with major depressive disorder

WV Bobo, B Van Ommeren… - Expert review of …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction The efficacy of antidepressants for patients with major depressive disorder
(MDD) varies from individual to individual, making the prediction of therapeutic outcomes …

Machine learning, pharmacogenomics, and clinical psychiatry: predicting antidepressant response in patients with major depressive disorder.

WV Bobo, B Van Ommeren… - Expert Review of Clinical …, 2022 - europepmc.org
The efficacy of antidepressants for patients with major depressive disorder (MDD) varies
from individual to individual, making the prediction of therapeutic outcomes difficult. Better …
[PDF] nsf.gov

[PDF][PDF] Machine learning, pharmacogenomics, and clinical psychiatry: predicting antidepressant response in patients with major depressive disorder

WV Bobo, B Van Ommeren, AP Athreya - EXPERT REVIEW OF …, 2022 - par.nsf.gov
Introduction: The efficacy of antidepressants for patients with major depressive disorder
(MDD) varies from individual to individual, making the prediction of therapeutic outcomes …